Thomas Buettner
-
- Radiopharmaceutical Chemistry and Applications 4
- Monoclonal and Polyclonal Antibodies Research 2
-
- Celiac Disease Research and Management 2
-
- SARS-CoV-2 and COVID-19 Research 2
- COVID-19 Clinical Research Studies 2
-
- Microscopic Colitis 2
- Acute Ischemic Stroke Management 2
-
- Systemic Lupus Erythematosus Research 2
- Co-authors
- Judith M. ConnettRichard LaforestJason S. LewisYasuhisa FujibayashiMichael J. WelchSheng-Kwei SongCarolyn J. AndersonDirk Roggenbuck
- Journals
- PLoS Pathogens (1 paper)Clinical Chemistry and Laboratory Medicine (CCLM) (1 paper)Journal of Medical Primatology (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Thomas Buettner
13 papers receiving 447 citations
Peers
Comparison fields: 5 of 79
- Radiology, Nuclear Medicine and Imaging 202
- Nephrology 34
- Pulmonary and Respiratory Medicine 124
- Oncology 89
- Gastroenterology 13
Countries citing papers authored by Thomas Buettner
This map shows the geographic impact of Thomas Buettner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Buettner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Buettner more than expected).
Fields of papers citing papers by Thomas Buettner
This network shows the impact of papers produced by Thomas Buettner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Buettner. The network helps show where Thomas Buettner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Buettner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2021 | 26 | |
| 3 | 2013 | 15 | |
| 4 | 2012 | 25 | |
| 5 | 2011 | 14 | |
| 6 | 2009 | 28 | |
| 7 | Copper-64-pyruvaldehyde-bis(N(4)-methylthiosemicarbazone) for the prevention of tumor growth at wound sites following laparoscopic surgery: monitoring therapy response with microPET and magnetic resonance imaging. | 2002 | 32 |
| 8 | 2001 | 42 | |
| 9 | 2001 | 177 | |
| 10 | Maximum tolerated dose and large tumor radioimmunotherapy studies of 64Cu-labeled monoclonal antibody 1A3 in a colon cancer model. | 1999 | 19 |
| 11 | 1990 | 24 | |
| 12 | 1985 | 27 | |
| 13 | 1983 | 31 |
About Thomas Buettner
Thomas Buettner is a scholar working on Gastroenterology, Nephrology and Internal Medicine, having authored 13 papers that have together received 462 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Microscopic Colitis (2 papers), Acute Ischemic Stroke Management (2 papers), Celiac Disease Research and Management (2 papers), Systemic Lupus Erythematosus Research (2 papers), COVID-19 Clinical Research Studies (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (202 citations), Nephrology (34 citations) and Pulmonary and Respiratory Medicine (124 citations). Thomas Buettner has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Judith M. Connett, Richard Laforest, Jason S. Lewis, Yasuhisa Fujibayashi, Michael J. Welch, Sheng-Kwei Song, Carolyn J. Anderson, Dirk Roggenbuck, M. Benjamin Perryman and Arnold W. Strauss. Their work appears in journals such as PLoS Pathogens, Clinical Chemistry and Laboratory Medicine (CCLM), Journal of Medical Primatology, Kidney International and European Journal of Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.